Sfoglia per Autore
F-33 Early ribavirin plasma concentration and ITPA polymorphisms as determinants of anemia after one month of anti-HCV therapy
2012-01-01 GP Caviglia; A D'Avolio; A Ciancio; A De Nicolò; L Boglione; ML Abate; C Rosso; A Smedile; G Cariti; J Cusato; M Simiele; M Rizzetto; G Di Perri
Development and validation of a useful HPLC-UV method for quantification of total and phosphorylated-ribavirin in blood and erythrocytes of HCV+ patients
2012-01-01 A. D'Avolio;A. De Nicolò;M. Simiele;S. Turini;D. Agnesod;L. Boglione;J. Cusato;L. Baietto;G. Cariti;A. Calcagno;M. Sciandra;G. Di Perri;S. Bonora
Early ribavirin plasma concentrations as predictor of anemia onset after one month of anti-HCV therapy in ITPA stratified population
2013-01-01 Amedeo De Nicolò; Jessica Cusato; Lucio Boglione; Alessia Ciancio; Antonina Smedile; Danilo Agnesod; Giuseppe Cariti; Mario Rizzetto; Giovanni Di Perri; Antonio D'Avolio
Could ritonavir intracellular concentrations have a role as active drugs when used as a booster PIs?
2013-01-01 Antonio D'Avolio; Amedeo De Nicolò; Marco Simiele; Lorena Baietto; Andrea Calcagno; Mauro Sciandra; Laura Trentini; Cristina Tettoni; Letizia Marinaro; Giovanni Di Perri; Stefano Bonora
Early ribavirin concentration is a critical response factor in the sub-population of patients infected by HCV-1 and unfavourable IL28B genotype
2013-01-01 Amedeo De Nicolò; Jessica Cusato; Lucio Boglione; Francesca Patti; Alessia Ciancio; Antonina Smedile; Danilo Agnesod; Giuseppe Cariti; Mario Rizzetto; Giovanni Di Perri; Antonio D'Avolio
A UPLC-MS/MS method for the simultaneous plasma quantification of all isomeric forms of the new anti-HCV protease inhibitors boceprevir and telaprevir.
2013-01-01 D'Avolio A;De Nicolò A;Agnesod D;Simiele M;Mohamed Abdi A;Dilly Penchala S;Boglione L;Cariti G;Di Perri G
Association of ITPA polymorphisms rs6051702/rs1127354 instead of rs7270101/rs1127354 as predictor of ribavirin-associated anemia in chronic hepatitis C treated patients.
2013-01-01 D'Avolio, Antonio; DE NICOLO', Amedeo; Cusato, Jessica; Ciancio, Alessia; Boglione, Lucio; Strona, Silvia; Cariti, G; Troshina, G; Caviglia, GIAN PAOLO; Smedile, Antonina; Rizzetto, Mario; DI PERRI, Giovanni
Sequential therapy with entecavir and PEG-INF in patients affected by chronic hepatitis B and high levels of HBV-DNA with non-D genotypes.
2013-01-01 Boglione L;D'Avolio A;Cariti G;Milia MG;Simiele M;De Nicolò A;Ghisetti V;Di Perri G
Quantification of tacrolimus in PBMCs samples in pediatric liver transplant patients and correlation with tacrolimus whole blood concentration
2014-01-01 Pinon M; Calvo PL; D’Avolio A; Pensi D; Brunati A; Canaparo R; De Nicolò A; Carbonaro G; Cerrina A; Di Perri G; Romagnoli R; Barbera C; Salizzoni M
Development and validation of an UPLC MS-MS method for the quantification of new direct antiretroviral agents simeprevir, daclatasvir sofosbuvir and its metabolite GS-332007 in human plasma
2014-01-01 Ariaudo A; Simiele M; De Nicolò A; Boglione L; Di Perri G; D'Avolio A
Pharmacokinetic of doxorubicin during chemotherapy in HIV patients affected by Hodgkin disease and Non- Hodgkin’s Lymphoma: the PKCT study
2014-01-01 A. Carbone; A. Calcagno; M. Guffanti; A. D'Avolio; L. Galli; A. De Nicolo; A. Galli; V. Castagna; A. Lazzarin; A. Castagna; N. Gianotti; S. Bonora
An UPLC MS/MS method coupled with automated on-line solid phase extraction for quantification of tacrolimus in PBMC samples
2014-01-01 Pensi D; De Nicolò A; Pinon M; Calvo PL; Di Perri G; D'Avolio A
Intracellular antiviral activity of low-dose ritonavir in boosted protease inhibitors regimens.
2014-01-01 De Nicolò A;Simiele M;Calcagno A;Mohamed Abdi A;Bonora S;Di Perri G;D'Avolio A
No pharmacokinetic interaction between raltegravir and amlodipine: importance for co-prescribing in ageing HIV-infected individuals
2014-01-01 Gurmit J. Singh;Akil Jackson;Antonio D’Avolio;Laura Else;Amedeo De Nicolò;Stefano Bonora;Giovanni Di Perri;Saye Khoo;David Back;Graeme Moyle;Marta Boffito
Significant early higher ribavirin plasma concentrations in patients receiving a triple therapy with pegylated interferon, ribavirin and telaprevir
2014-01-01 Boglione, Lucio; DE NICOLO', Amedeo; Cusato, Jessica; Cariti, G.; DI PERRI, Giovanni; D'Avolio, Antonio
Triple or dual therapy for HCV-1 naive patients? Optimizing selection tools.
2014-01-01 Boglione L;De Nicolò A;Di Perri G;D'Avolio A
Identification of naïve HVC-4 patients who may be treated with pegylated-interferon and ribavirin according to IL28B polymorphisms.
2014-01-01 Boglione L;Cusato J;De Nicolò A;Cariti G;Allegra S;Ghisetti V; Di Perri G;D'Avolio A
A concentration-dependent pharmacokinetic interaction with telaprevir increases ribavirin concentrations and leads to higher haemoglobin drop
2014-01-01 A. De Nicolò; A. Ciancio; L. Boglione; A. Mohamed Abdi; A. Smedile; G.P. Caviglia; G. DI Perri; M. Rizzetto; A. D'Avolio
Pharmacokinetic and pharmacogenetic analysis of tacrolimus in pediatric liver transplant patients in the early post-liver transplantation period
2014-01-01 Calvo PL; Pinon M; Canaparo R; D’Avolio A; Brunati A; Pensi D; De Nicolò A; Carbonaro G; Cerrina A; Nonnato A; Romagnoli R; Barbera C; Salizzoni M
The co-administration of telaprevir increases ribavirin plasma and intra-erythrocytic concentrations, causing higher onset of anemia
2014-01-01 A. De Nicolò;A. Ciancio;L. Boglione;A. Mohamed Abdi;A. Smedile;G.P. Caviglia;G. Di Perri;M. Rizzetto;A. D’Avolio
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile